Chimeric Newcastle Disease Virus Vectors Expressing Human IFN-γ Mediate Target Immune Responses and Enable Multifaceted Treatments
The therapeutic potential of Newcastle disease virus (NDV) has been reported as both an oncolytic agent and a vaccine vector against many antigens. However, in the individuals already immunized with NDVs, second and subsequent administration does not provide substantial benefits. In this study, two...
Main Authors: | Rofaida Mostafa Soliman, Keisuke Nishioka, Tomo Daidoji, Osamu Noyori, Takaaki Nakaya |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/2/455 |
Similar Items
-
Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein
by: Rofaida Mostafa Soliman, et al.
Published: (2024-02-01) -
Safety and efficacy of recombinant newcastle disease virus expressing human interleukin-12 as a potential vaccine in breast cancer
by: Mohamed Amin, Zahiah
Published: (2019) -
Construction of Novel Thermostable Chimeric Vaccine Candidates for Genotype VII Newcastle Disease Virus
by: Yongzhong Cao, et al.
Published: (2022-12-01) -
Residues 315 and 369 in HN Protein Contribute to the Thermostability of Newcastle Disease Virus
by: Baoyang Ruan, et al.
Published: (2020-09-01) -
Spray vaccination against Newcastle disease: efficacy of Newcastle disease V4 vaccine
by: Ibrahim, A. Latif
Published: (1979)